BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Melanoma Institute Australia - ECPv6.17.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://melanoma.org.au
X-WR-CALDESC:Events for Melanoma Institute Australia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Melbourne
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260805
DTEND;VALUE=DATE:20260808
DTSTAMP:20260331T012114Z
CREATED:20260331T012114Z
LAST-MODIFIED:20260331T012114Z
UID:10000279-1785888000-1786147199@melanoma.org.au
SUMMARY:MOGA Annual Scientific Meeting
DESCRIPTION:The 2026 MOGA Annual Scientific Meeting (ASM) will bring together Australian medical oncologists to reflect on a timely theme: \nReimagining Cancer Care: Is Less Doing More? \nIn recent years\, oncology has found itself at a fascinating crossroads. With ever-deepening insights into tumour biology\, immunotherapy\, molecular profiling\, and patient-centred care\, we are beginning to ask a powerful and\, at times\, uncomfortable question: Are we sometimes doing too much? \nWe are now confronting the possibility that treatment de-escalation is not just a compromise\, but potentially a pathway to more humane\, precise\, and effective care. This conversation extends well beyond protocols and guidelines. It challenges us to think deeply about patient autonomy\, shared decision-making\, and what quality of life truly means in the era of personalised medicine. \nThis ASM will bridge disciplines and perspectives—from surgical oncology to medical and radiation oncology\, to palliative care and psychosocial support. We will consider not only clinical evidence\, but also the ethical\, logistical\, and emotional dimensions of doing less. We will look at emerging biomarkers and novel drug targets that allow us to fine-tune therapy like never before. Exploring what it means to personalise care in the truest sense—not just through science\, but through listening. \nLocation: RACV Royal Pines\, Gold Coast\, Australia \nKey Dates: \nEarly Bird Registrations Close: 14 June 2026\nAbstract Submissions Close: 14 June 2026\nAbstract Selection Advice: 3 July 2026\nAbstract Acceptance by Presenter: 10 July 2026\nTravel Award Applications Open: 3 July 2026\nTravel Award Applications Close: 10 July 2026\nTravel Award Recipient Notification: 17 July 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/moga-annual-scientific-meeting/
LOCATION:RACV Royal Pines Resort\, Ross Street\, Gold Coast\, Queensland\, 4217\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/MOGA-Asm-600-x-338-px-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260805T170000
DTEND;TZID=Australia/Sydney:20260805T170000
DTSTAMP:20260701T003251Z
CREATED:20260618T043103Z
LAST-MODIFIED:20260701T003251Z
UID:10000309-1785949200-1785949200@melanoma.org.au
SUMMARY:MRFF Preventive and Public Health Research Initiative - 2026 Consumer-Led Research Grant
DESCRIPTION:The Medical Research Future Fund (MRFF) – 2026 Consumer-Led Research Grant Opportunity will support research that: \n\nStream 1 (Incubator): identify health priorities\, develop new approaches and/or methodologies and conduct pilot studies addressing health issues and/or barriers that:\n\nare co-led\, co-produced and/or co-designed with consumers\nare in partnership with health services\nincrease consumers’ understanding of\, and involvement in\, research.\n\n\n\n\nStream 2 (Targeted Call for Research): develop and/or test scalable and sustainable approaches\, in partnership with consumers\, that enable self-care interventions or improve quality of life and/or survivorship care. Approaches are for individuals from one or more priority populations\, who have experienced or are experiencing long term diseases and conditions. Approaches may\, where appropriate\, also deliver for the individual’s families\, carers and communities.\nTopic A: Research projects that focus on cancer\nTopic B: Research projects that focus on long term physical diseases and conditions other than cancer\nTopic C: Research projects that focus on mental health challenges\, diseases or conditions.\n\nThe anticipated outcome of the research is to improve the health and wellbeing of Australians by: \n\nStream 1 (Incubator): developing effective approaches for addressing health priorities for communities and that build capability for consumer involvement in research\nStream 2 (Targeted Call for Research): developing effective approaches to improve the health and/or wellbeing for those who have experienced or are experiencing long term diseases and conditions\n\n\nKey Dates:\nMinimum data due: 8 July 2026\nApplications close: 5 August 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-consumer-led-research-grant/
LOCATION:NSW
CATEGORIES:Grants,Discovery
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/06/MRFF-PPHRI_Consumer-Led-Research-Grant-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260819T170000
DTEND;TZID=Australia/Sydney:20260819T170000
DTSTAMP:20260505T060732Z
CREATED:20260505T060732Z
LAST-MODIFIED:20260505T060732Z
UID:10000293-1787158800-1787158800@melanoma.org.au
SUMMARY:MRFF Genomics Health Futures
DESCRIPTION:The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that: \nStream 1 (TCR): develop genomic tools and technologies to identify genetic predisposition to cancer and improve screening and targeted intervention. Focus on increased access to genomic testing and on liquid biopsy. \nStream 2 (TCR): conduct scalable research to enhance novel gene discoveries\, increase diagnostic rates and enable disease modelling to support development of targeted therapies or prevention strategies. \nStream 3 (Incubator): develop novel methods for using polygenic risk scores to identify subgroups of the population at high risk of common and complex diseases (cardiovascular disease\, diabetes and other common and/or complex diseases). \nStream 4 (Incubator): develop novel methods for improving accuracy and usefulness of polygenic risk scores to stratify people with common cancers for surveillance and treatment (breast cancer\, colorectal cancer\, prostate cancer and other common cancers) \nStream 5 (TCR): undertake research to enhance or streamline uptake of clinical genomics into practice. \nStream 6 (Accelerator): develop and maintain infrastructure to support research collaboration by enabling data sharing\, portability\, longevity and connectivity of analysis across Australia. Research conducted should address emerging ethical\, legal and social issues associated with the governance of clinical and genomic datasets with particular focus on the application of advanced analytics (e.g. AI) to enhance the diagnostic utility of genomics. \nApplicants must propose research that addresses these objectives and those of the Genomics Health Futures Mission as outlined in the Roadmap and Implementation Plan. \nKey Dates \n\nMinimum data due date: 22 July 2026\nApplications close: 19 August 2026\nIndicative funding status: Funding anticipated to be awarded from June 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-genomics-health-futures/
LOCATION:NSW
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/MRFF-Genomics-Health-Futures600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260819T170000
DTEND;TZID=Australia/Sydney:20260819T170000
DTSTAMP:20260602T045536Z
CREATED:20260602T045536Z
LAST-MODIFIED:20260602T045536Z
UID:10000303-1787158800-1787158800@melanoma.org.au
SUMMARY:MRFF EMCR Initiative - Early to Mid-Career Researchers Grant
DESCRIPTION:The Medical Research Future Fund (MRFF) –2026 Early to Mid-Career Researchers Grant Opportunity will support research to build and grow research capacity and capability in Australia by supporting Early to Mid-Career Researchers (EMCRs) to continue their health and medical research careers. \nThe objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that: \n\nStream 1 (Incubator): conduct early stage\, small scale research\, led by early career researchers\, that seeks to assess the potential and feasibility of novel strategies to address a critical or intractable health issue in one or more Priority Populations.\nStream 2 (Accelerator): establish a large-scale interdisciplinary research program\, led by mid-career researchers\, that drives implementation of substantial improvements to health care and/or health system effectiveness for one or more Priority Populations.\nStream 3 (Targeted Call for Research): utilise co-funding to accelerate the translation of research led by early or mid-career researchers into policy and practice. (Note: a priority population focus is not required).\n\nThe intended outcome of the research is to improve the health and wellbeing of Australians by: \n\nStream 1 (Incubator): supporting early career researchers to develop innovative solutions for addressing significant health challenges in Priority Populations.\nStream 2 (Accelerator): supporting mid-career researchers to transform health practice and/or policy for Priority Populations.\nStream 3 (Targeted Call for Research): supporting early to mid-career researchers to translate new health solutions into practice.\n\n\nKey Dates:\nMinimum data due: 22 July 2026\nApplications close: 19 August 2026\nGrant activity timeframe: February 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-emcr-initiative/
LOCATION:NSW
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/06/MRFF-EMCR-Initiative-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260821T170000
DTEND;TZID=Australia/Sydney:20260821T170000
DTSTAMP:20260618T060727Z
CREATED:20260618T060727Z
LAST-MODIFIED:20260618T060727Z
UID:10000311-1787331600-1787331600@melanoma.org.au
SUMMARY:TOUR DE CURE Annual Grants
DESCRIPTION:We are proud to open a new Annual Grants Round in 2026\, made possible by the continued support of our community\, partners\, and fundraisers. \nThis year’s Grant Round is open to applications in the following categories: \n• Early Career Research Grant\n• PhD Scholarship\n• Prof Richard Scolyer Award for Brain Cancer Research for Early\, Mid and Senior Career Researchers \nThe Tour de Cure Grants Committee follows an ethical\, independent\, and transparent selection process when reviewing applications. \nWe are committed to funding innovation and excellence\, using our resources to support the best Australian-based projects and researchers. As a cancer-agnostic organisation\, we consider applications across all cancer types. \nDemonstrating a rigorous selection process\, choosing the strongest projects\, and maintaining sound project governance – all grant applications are assessed on merit. \nAn EOI (Expression of Interest) is required for all research grant categories listed. EOIs are reviewed in Round One by the Tour de Cure Grants Committee. Successful applicants are then invited to submit a full grant application in Round Two\, which is assessed in detail by the Grants Committee who then makes recommendations to the TDC Board for final decisions in December. \nInstitutions supporting individual researchers may submit no more than two applications per grant category. This limit applies even where an intermediary body\, such as a foundation\, applies on behalf of the researcher. There is no limit on the number of PhD Scholarship applications but please be mindful of your submission numbers. \n\nKey Dates:\nExpressions of Interest open: 1 August 2026\nExpressions of Interest close: 21 August 2026\nExpressions of Interest outcomes notified: 8 October 2026\nFull grant applications open (by invitation): 9 October 2026\nFull grant applications close: 24 October 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/tour_de_cure_grants/
LOCATION:NSW
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/06/Tour-de-Cure_Grants-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260830
DTEND;VALUE=DATE:20260831
DTSTAMP:20251024T040143Z
CREATED:20251016T032249Z
LAST-MODIFIED:20251024T040143Z
UID:10000208-1788048000-1788134399@melanoma.org.au
SUMMARY:2026 TCS Sydney Marathon presented by ASICS
DESCRIPTION:Whether you’re chasing your debut or your next star\, the TCS Sydney Marathon presented by ASICS is your moment to shine. \nSydney is the bucket-list race that redefines what’s possible\, so come experience the place where the world comes to finish. \nWhen you nominate MIA as your charity of choice\, funds raised support our life-saving melanoma research\, so we can reach our mission of zero deaths from melanoma. \nMake sure you set up your fundraising page\, as well as registering for the event – both can be done at the link below. \nREGISTER NOW
URL:https://melanoma.org.au/event/2026-tcs-sydney-marathon-presented-by-asics/
LOCATION:NSW
CATEGORIES:Fundraiser,Running Events
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2025/06/TCS-Sydney-Marathon-2025.jpg
END:VEVENT
END:VCALENDAR